Prostatic Neoplasms: all 6,484 studies
Page 43 of 65. Open to participants first (1,413), then studies with results posted, then the rest; newest registration first within each.
- Bicalutamide and Raloxifene Hydrochloride in Treating Patients With Prostate Cancer Undergoing SurgeryWithdrawnNCT03147196Phase 2
- Standard Treatment +/- SBRT in Solid Tumors Patients With Between 1 and 5 Bone-only MetastasesActive, not recruitingNCT03143322Not applicable
- Randomized Phase II Study of Salvage XRT + ADT +/- Abiraterone and Apalutamide for Rising PSA After RP (FORMULA-509)Status unknownNCT03141671Phase 2
- A Phase I Study of PCUR-101 in Combination With Androgen Suppression Therapy in the Treatment of Patients With Metastatic Castration-Resistant Prostate CancerTerminatedNCT03137758Phase 1
- Repurposing Metformin as Anticancer Drug: in Advanced Prostate CancerStatus unknownNCT03137186Phase 2
- ModraDoc006/r in Metastatic Castration-resistant Prostate CancerCompletedNCT03136640Phase 1
- PSA TOOL for Prostate Cancer Screening DiscussionsCompletedNCT03135444Not applicable
- Diagnostic Imaging of Bone Metastases in Prostate Cancer PatientsStatus unknownNCT03134261Not applicable
- Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)CompletedNCT03133286
- Androgen Deprivation Therapy (ADT) Versus ADT Plus Prostate Cryotherapy for Metastatic Prostate Cancer (mPCa)Status unknownNCT03129854Not applicable
- Prostate Cancer SurveyCompletedNCT03128710
- A Study for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer PatientsActive, not recruitingNCT03127631Not applicable
- Effect of Enzalutamide Dose Reduction on Fatigue, Cognition, and Drug Trough Levels in Patients With Prostate CancerStatus unknownNCT03124615Phase 2
- Neoadjuvant Apalutamide (ARN509) and Radical Prostatectomy in Treatment of Intermediate to High Risk Prostate CancerCompletedNCT03124433Phase 2
- Enzalutamide and Niclosamide in Treating Patients With Recurrent or Metastatic Castration-Resistant Prostate CancerCompletedNCT03123978Phase 1
- Collection of Serum Samples in Studying Emotional Stress in Patients With Prostate CancerCompletedNCT03122743
- Correlation of Imaging Findings With Clinical Findings and Patient Outcomes in Prostate CancerWithdrawnNCT03122470Not applicable
- Early Rising PSA Endocrine Treatment Versus Chemo-endocrine Therapy- SPCG14Status unknownNCT03119857Phase 3
- Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their PartnersCompletedNCT03112668Not applicable
- Phase I Trial of PACE for Metastatic Prostate CancerWithdrawnNCT03110588Phase 1
- Repeatability of Positron Emission Tomography (TEP) With fluorométhyl-(18F)-diméthyl-2-hydroxyéthyl-ammoniumCompletedNCT03105869Not applicable
- Prostatic Artery Embolization for Obstructive Uropathy Due to Prostate CancerCompletedNCT03104907Not applicable
- A Phase II Study Evaluating the Efficacy of Enzalutamide and the Role of ARv7 in Metastatic Castration Resistant Prostate Cancer (mCRPC) Patients With Visceral Disease.CompletedNCT03103724Phase 2
- Multiparametric Ultrasound Imaging in Prostate CancerStatus unknownNCT03101176Not applicable
- Treatment of Metastatic Castrate Resistant Prostate Cancer Patients According to Circulating Tumor Cells KineticCompletedNCT03101046Phase 2
- Online Mindfulness for Women Treated for Breast Cancer and Men Treated for Prostate CancerCompletedNCT03100981Not applicable
- Clinic Study of 18F-Al-NOTA-MATBBN in Cancer DiagnosticsStatus unknownNCT03094897Early Phase 1
- Multiparametric Ultrasound-Study for the Detection of Prostate CancerCompletedNCT03091231
- CART-PSMA-TGFβRDN Cells for Castrate-Resistant Prostate CancerActive, not recruitingNCT03089203Phase 1
- Expression of Molecular Markers in Circulating Tumor Cells of Metastatic Castration-Resistant Prostate CancerStatus unknownNCT03089099
- PALLiON - PALLiative Care In ONcologyCompletedNCT03088202Not applicable
- A Study of Grape Seed Extract in Asymptomatic Non-Metastatic Prostate Cancer Patients With Rising PSACompletedNCT03087903Not applicable
- Autologous Immune Cell Therapy in Combination With LHRH-a in Patients With mCRPCStatus unknownNCT03085966Phase 1/2
- Magnetic Resonance Whole Body Diffusion-Weighted Imaging in Finding Bone or Lymph Node Metastasis in Participants With High-Risk Prostate CancerActive, not recruitingNCT03085043Not applicable
- Olive Oil v Prostate Cancer Foundation Diet for Treatment of Prostate CancerCompletedNCT03084913Not applicable
- Prospective Validation of Prostate Biomarkers for Repeat BiopsyStatus unknownNCT03082274
- Intraprostatic PRX302 Injection to Treat Localised Prostate CancerCompletedNCT03081481Phase 2
- Neoadjuvant Degarelix With or Without Apalutamide (ARN-509) Followed by Radical ProstatectomyActive, not recruitingNCT03080116Phase 2
- Feasibility Study of Ultrasound Elastography Detecting Prostate CancerCompletedNCT03077126Not applicable
- Genetic Evaluation of Men (GEM)TerminatedNCT03076242
- Phase IB Trial of Radium-223 and Niraparib in Patients With Castrate Resistant Prostate Cancer (NiraRad)CompletedNCT03076203Phase 1
- Prospective Multicentre Cohort Study PROREPAIR-B (mCRPC)CompletedNCT03075735
- Safety, Tolerability and Pharmacokinetics of ONC1-0013B in Patients With Progressive Metastatic Castration-resistant Prostate CancerCompletedNCT03074032Phase 1
- Exercise Intervention Among Men With Prostate Cancer Initiating Androgen Deprivation TherapyCompletedNCT03070145Not applicable
- Oral Docetaxel (ModraDoc/r) in Combination With Hormonal Treatment and Radiation Therapy in High-risk Prostate CancerTerminatedNCT03066154Phase 1
- The Assessment of the Feasibility of a Home Based Exercise Programme in the Older Patient Following Major SurgeryCompletedNCT03064308Not applicable
- Metabolic Change in Prostate Cancer Bone Metastases on 68Ga-HBED-CC-PSMA PET/CT Following Radium-223 TherapyCompletedNCT03062254Phase 2
- Effects of Urinary Bladder Hypertrophy on Urge Urine Incontinence After Radical ProstatectomyStatus unknownNCT03061760
- An Open Label Phase II Study of Biweekly Docetaxel Plus Androgen-Deprivation Therapy in Patients With Previously-Untreated, Metastatic, Prostatic AdenocarcinomaStatus unknownNCT03061643Phase 2
- Nivolumab and Ipilimumab Treatment in Prostate Cancer With an Immunogenic SignatureActive, not recruitingNCT03061539Phase 2
- Cabazitaxel in mCRPC Patients With AR-V7 Positive Circulating Tumor Cells (CTCs)Status unknownNCT03050866Phase 2
- Cohorts of Docetaxel or Cabazitaxel in Combination With the Potent CYP3A4 Inhibitor, ClarithromycinTerminatedNCT03043989Phase 1
- Idronoxil Suppository Combine With Radiotherapy for Metastatic Prostate CancerTerminatedNCT03041285Phase 1
- Nivolumab in Prostate Cancer With DNA Repair Defects (ImmunoProst Trial)Status unknownNCT03040791Phase 2
- Long-Term Follow-Up in Patients With Prostate Cancer After SurgeryCompletedNCT03035500Not applicable
- Neoadjuvant Listeria or Daratumumab in Prostate CancerWithdrawnNCT03035357Phase 2
- Whole-Body 3D T1-weighted MR Imaging Anatomical Sequences: GE mDixon vs FSE (View) Approaches in Prostate Cancer.CompletedNCT03034070Not applicable
- Metformin in Patients Initiating ADT as Prevention and Intervention of Metabolic SyndromeTerminatedNCT03031821Phase 3
- Effects of PEEP on Intracranial and Intraocular Pressure in Robot-assisted Laparoscopic Radical ProstatectomyStatus unknownNCT03031613Not applicable
- Clinical Evaluation of the 'ExoDx Prostate IntelliScore' (EPI)CompletedNCT03031418
- Use of an Experimental Radiopharmaceutical (131I-MIP-1095) in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)CompletedNCT03030885Phase 1
- Phase 1 Study to Evaluate the Pharmacokinetics and Safety Following SC Administration of DWJ108J in Patients With Prostate CancerStatus unknownNCT03029533Phase 1
- Survivorship Care Plans in a Community Oncology PracticeCompletedNCT03028584
- Evaluation of a Postural Rehabilitation Program Based on Sensory-motor Control in Men With Urinary Incontinence After ProstatectomyWithdrawnNCT03027986Not applicable
- Explaining the Invisible Using the PEARL SystemCompletedNCT03025633Not applicable
- Clinical Study of Atezolizumab (Anti-PD-L1) and Sipuleucel-T in Patients With Asymptomatic or Minimally Symptomatic Metastatic Castrate Resistant Prostate CancerCompletedNCT03024216Phase 1
- Laser Fluorescence in Cancer Surgical TreatmentStatus unknownNCT03021200Not applicable
- Evaluation of Neuroendocrine Differentiation as a Potential Mechanism of Tumor Recurrence Following RadiotherapyActive, not recruitingNCT03017794
- PC 360 SurvivorshipCompletedNCT03017456Not applicable
- A COMbined progRamme of Exercise and Dietary ADvice in mEn With Castrate Resistant Prostate CancerCompletedNCT03017417Not applicable
- To Evaluate the Criteria for Renewal of Luteinizing Hormone-Releasing Hormone (LHRH) Analogue Treatment in Prostate Cancer PatientsCompletedNCT03017313
- Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate CancerActive, not recruitingNCT03016741Phase 4
- Castration-resistant Prostate Cancer and Intra-prostatic Hormonal StatusWithdrawnNCT03014973Not applicable
- Ultrasound-Based Imaging Using the Aixplorer System in Diagnosing Prostate Cancer in Patients Undergoing BiopsyCompletedNCT03013413Not applicable
- Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair DefectsActive, not recruitingNCT03012321Phase 2
- Value of FLT PET/CT in Radium-223 Therapy of mCRPC PatientsTerminatedNCT03011749Not applicable
- Robotic Surgery After Focal Ablation TherapyCompletedNCT03011606Not applicable
- A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate CancerCompletedNCT03009981Phase 3
- Will Erectile Dysfunction Increase the Risk of Prostate CancerCompletedNCT03009123
- Correlation Between SUV on 18F-DCFPyL PET/CT and Gleason Score in Prostate CancerCompletedNCT03001895Phase 2
- 68Ga-PSMA PET/CT in Prostate CancerCompletedNCT03001869Phase 3
- Radiotherapy of Pelvic Lymph Nodes in High Risk Prostate Cancer - A Retrospective AnalysisCompletedNCT02998619
- A Phase 1/1b Study of MEDI3726 in Adults Subjects With Metastatic Castration Resistant Prostate CancerCompletedNCT02991911Phase 1
- Prostatectomies Using Einstein Vision® 3DCompletedNCT02991794
- Assess Gamma H2AX Positivity in Circulating Prostate Cancer Cells Before and After Radium 223CompletedNCT02981797
- A Pilot Study of [Ga-68]PSMA PET/MRI for the Assessment of PSMA-positive TumorsCompletedNCT02978586
- A Trial Assessing Post-Operative Use of ProSpare, a Rectal Obturator in Prostate Cancer RadiotherapyStatus unknownNCT02978014Phase 2
- Positive End-expiratory Pressure-induced Increase in Central Venous Pressure as a Predictor of Fluid Responsiveness in Robot-assisted Laparoscopic SurgeryCompletedNCT02977143Not applicable
- Intensity-modulated Radiation Therapy From 70Gy to 80Gy in Localized Prostate CancerCompletedNCT02974231
- Salvage Lymph Node Dissection in Prostate Cancer Patients With Recurrence After Radical ProstatectomyCompletedNCT02974075Not applicable
- ODM-201 vs Androgen Deprivation Therapy in Hormone naïve Prostate CancerActive, not recruitingNCT02972060Phase 2
- Trimodal (18)F-choline-PET/mpMRI/TRUS Targeted Prostate BiopsiesTerminatedNCT02971995Not applicable
- Staying Strong and Healthy During Androgen Deprivation Therapy (ADT) for MenCompletedNCT02969577Not applicable
- 18F-NaF-PET/MR vs 99mTc-MDP-SPECT/CT to Detect Bone Metastases in Prostate Cancer Patients.CompletedNCT02969564
- Focal ExAblate MR-Guided Focused Ultrasound Treatment for Management of Organ-Confined Intermediate Risk Prostate CancerTerminatedNCT02968784Not applicable
- Durvalumab in Treating Patients With Metastatic Hormone-Resistant Prostate CancerWithdrawnNCT02966587Phase 2
- The Effect of Prolonged Inspiratory Time on Gas Exchange During Robot-assisted Laparoscopic Surgery With Steep Trendelenburg Position : A Crossover Randomized Clinical TrialCompletedNCT02966535Not applicable
- uPAR PET/CT in Radium-223-dichloride Treatment of Patients With Metastatic Castration-resistant Prostate CancerTerminatedNCT02964988Phase 2
- Incidence of Second Primary Malignancies in Prostate Cancer Patients With Bone Metastases - an Observational Retrospective Cohort Study in SwedenCompletedNCT02963675
- Study of Natural Killer Cells in Patients With Metastatic Prostate Cancer: Relationship With Survival and Response Time to CastrationCompletedNCT02963155Not applicable